Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates

[1]  W. Nauseef,et al.  Isolation of Human Neutrophils from Venous Blood. , 2019, Methods in molecular biology.

[2]  J. Santibañez,et al.  How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions , 2019, Cancer Immunology, Immunotherapy.

[3]  G. Adema,et al.  Interactions among myeloid regulatory cells in cancer , 2018, Cancer Immunology, Immunotherapy.

[4]  Yumei He,et al.  Endoplasmic reticulum stress induced LOX‐1+ CD15+ polymorphonuclear myeloid‐derived suppressor cells in hepatocellular carcinoma , 2018, Immunology.

[5]  Hongwei Liang,et al.  Tumor conditions induce bone marrow expansion of granulocytic, but not monocytic, immunosuppressive leukocytes with increased CXCR2 expression in mice , 2018, European journal of immunology.

[6]  L. Joosten,et al.  Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity , 2018, Cell.

[7]  Kimberly J. Hassett,et al.  Rhesus Macaque Myeloid-Derived Suppressor Cells Demonstrate T Cell Inhibitory Functions and Are Transiently Increased after Vaccination , 2018, The Journal of Immunology.

[8]  E. Jensen,et al.  Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation , 2017, Nature Medicine.

[9]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.

[10]  A. Beineke,et al.  Identification of a Novel Subset of Myeloid-Derived Suppressor Cells During Chronic Staphylococcal Infection That Resembles Immature Eosinophils , 2017, The Journal of infectious diseases.

[11]  C. Uyttenhove,et al.  Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes , 2017, Nature Communications.

[12]  Bernd Bodenmiller,et al.  miCAT: A toolbox for analysis of cell phenotypes and interactions in multiplex image cytometry data , 2017, Nature Methods.

[13]  Amit A. Patel,et al.  The fate and lifespan of human monocyte subsets in steady state and systemic inflammation , 2017, The Journal of experimental medicine.

[14]  C. Poets,et al.  Granulocytic myeloid‐derived suppressor cells from human cord blood modulate T‐helper cell response towards an anti‐inflammatory phenotype , 2017, Immunology.

[15]  R. Koup,et al.  Neutrophils acquire the capacity for antigen presentation to memory CD4+ T cells in vitro and ex vivo. , 2017, Blood.

[16]  Adam A. Margolin,et al.  Quantitative Multiplex Immunohistochemistry Reveals Myeloid-Inflamed Tumor-Immune Complexity Associated with Poor Prognosis. , 2017, Cell reports.

[17]  E. Zoratti,et al.  Mature CD10+ and immature CD10- neutrophils present in G-CSF-treated donors display opposite effects on T cells. , 2017, Blood.

[18]  P. Robbins,et al.  Expansion of myeloid‐derived suppressor cells with aging in the bone marrow of mice through a NF‐κB‐dependent mechanism , 2017, Aging cell.

[19]  S. Armstrong,et al.  Myeloid progenitor cluster formation drives emergency and leukemic myelopoiesis , 2017, Nature.

[20]  D. Gabrilovich.  Myeloid-Derived Suppressor Cells , 2017, Cancer Immunology Research.

[21]  Kimberly R. Jordan,et al.  Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients , 2017, Cancer Immunology, Immunotherapy.

[22]  M. Cassatella,et al.  Human neutrophils in the saga of cellular heterogeneity: insights and open questions , 2016, Immunological reviews.

[23]  P. Wesseling,et al.  Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function. , 2016, Neuro-oncology.

[24]  A. Lewandowska-Sabat,et al.  Transient Migration of Large Numbers of CD14++ CD16+ Monocytes to the Draining Lymph Node after Onset of Inflammation , 2016, Front. Immunol..

[25]  George A. Dominguez,et al.  Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients , 2016, Science Immunology.

[26]  Peter J. Murray,et al.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards , 2016, Nature Communications.

[27]  A. Zhao,et al.  Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway. , 2016, Molecular human reproduction.

[28]  J. Pollard,et al.  Isolation of Mouse and Human Tumor-Associated Macrophages. , 2016, Advances in experimental medicine and biology.

[29]  S. Brandau,et al.  Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells. , 2016, Seminars in immunology.

[30]  H. Abele,et al.  Granulocytic Myeloid-Derived Suppressor Cells Accumulate in Human Placenta and Polarize toward a Th2 Phenotype , 2016, The Journal of Immunology.

[31]  S. Ugel,et al.  MDSCs in cancer: Conceiving new prognostic and therapeutic targets. , 2016, Biochimica et biophysica acta.

[32]  S. H. van der Burg,et al.  Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study , 2016, Cancer Immunology, Immunotherapy.

[33]  F. Issa.  Research Highlights , 2015, Nature Biotechnology.

[34]  Y. Meirow,et al.  Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate , 2015, Front. Immunol..

[35]  R. Mukherjee,et al.  Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous , 2015, Scientific Reports.

[36]  Jeff W. Lichtman,et al.  Clarifying Tissue Clearing , 2015, Cell.

[37]  Helena Jernström,et al.  Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients , 2015, PloS one.

[38]  J. Utikal,et al.  Elevated chronic inflammatory factors and myeloid‐derived suppressor cells indicate poor prognosis in advanced melanoma patients , 2015, International journal of cancer.

[39]  M. Kortylewski,et al.  TLR9-Targeted STAT3 Silencing Abrogates Immunosuppressive Activity of Myeloid-Derived Suppressor Cells from Prostate Cancer Patients , 2015, Clinical Cancer Research.

[40]  Akio Ohta,et al.  Immunological mechanisms of the antitumor effects of supplemental oxygenation , 2015, Science Translational Medicine.

[41]  L. Levy,et al.  Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. , 2015, Cell reports.

[42]  S. Singhal,et al.  An optimized disaggregation method for human lung tumors that preserves the phenotype and function of the immune cells , 2015, Journal of leukocyte biology.

[43]  S. Ostrand-Rosenberg,et al.  Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment. , 2015, Advances in cancer research.

[44]  L. Rydén,et al.  A high frequency of MDSCs in sepsis patients, with the granulocytic subtype dominating in gram‐positive cases , 2014, Journal of leukocyte biology.

[45]  Yan Cui,et al.  The stress-response sensor chop regulates the function and accumulation of myeloid-derived suppressor cells in tumors. , 2014, Immunity.

[46]  C. Poets,et al.  Granulocytic myeloid derived suppressor cells expand in human pregnancy and modulate T‐cell responses , 2014, European journal of immunology.

[47]  N. Anstey,et al.  Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients , 2014, Critical Care.

[48]  N. Hockstein,et al.  ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. , 2014, The Journal of clinical investigation.

[49]  F. Qiu,et al.  γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. , 2014, Immunity.

[50]  P. Dessen,et al.  PD-L1 is a novel direct target of HIF-1α, and its blockade under hypoxia enhanced MDSC-mediated T cell activation , 2014, The Journal of experimental medicine.

[51]  P. Goepfert,et al.  Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway , 2014, PLoS pathogens.

[52]  N. Kiwanuka,et al.  Characterization of Neutrophil Subsets in Healthy Human Pregnancies , 2014, PloS one.

[53]  W. Nauseef.  Isolation of human neutrophils from venous blood. , 2014, Methods in molecular biology.

[54]  H. Moses,et al.  The roles of TGFβ in the tumour microenvironment , 2013, Nature Reviews Cancer.

[55]  J. Talmadge,et al.  History of myeloid-derived suppressor cells , 2013, Nature Reviews Cancer.

[56]  I. Müller,et al.  Phenotypic Alteration of Neutrophils in the Blood of HIV Seropositive Patients , 2013, PloS one.

[57]  Jason B. Williams,et al.  Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells , 2013, Science Translational Medicine.

[58]  R. Germain,et al.  The future of immunoimaging — Deeper, bigger, more precise, and definitively more colorful , 2013, European journal of immunology.

[59]  C. Carmona-Rivera,et al.  Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity , 2013, Seminars in Immunopathology.

[60]  I. Müller,et al.  Characterization of a Novel Population of Low-Density Granulocytes Associated with Disease Severity in HIV-1 Infection , 2012, PloS one.

[61]  W. Wick,et al.  Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion. , 2012, Cancer research.

[62]  S. Lang,et al.  Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology , 2012, Cancer Immunology, Immunotherapy.

[63]  J. V. Van Ginderachter,et al.  G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. , 2012, Clinical immunology.

[64]  D. Gabrilovich,et al.  Coordinated regulation of myeloid cells by tumours , 2012, Nature Reviews Immunology.

[65]  S. Wong,et al.  The three human monocyte subsets: implications for health and disease , 2012, Immunologic Research.

[66]  P. Dahm,et al.  Circulating and tumor‐infiltrating myeloid cell subsets in patients with bladder cancer , 2012, International journal of cancer.

[67]  Daniel G. Anderson,et al.  Origins of tumor-associated macrophages and neutrophils , 2012, Proceedings of the National Academy of Sciences.

[68]  S. Biswas,et al.  Characterization of the nature of granulocytic myeloid‐derived suppressor cells in tumor‐bearing mice , 2012, Journal of leukocyte biology.

[69]  S. Serrano,et al.  B–helper neutrophils stimulate immunoglobulin diversification and production in the marginal zone of the spleen , 2011, Nature Immunology.

[70]  A. Sevko,et al.  Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation , 2012, Cancer Immunology, Immunotherapy.

[71]  S. Serrano,et al.  B – helper neutrophils stimulate immunoglobulin diversification and production in the marginal zone of the spleen , 2016 .

[72]  I. Biaggioni,et al.  Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells , 2011, The Journal of Immunology.

[73]  B. Kleinschmidt-DeMasters,et al.  Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. , 2011, Clinical cancer research : an official journal of the American Association for Cancer Research.

[74]  L. Lazzarato,et al.  Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells , 2011, The Journal of experimental medicine.

[75]  Wing-Cheong Wong,et al.  Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. , 2011, Blood.

[76]  B. Rini,et al.  Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma. , 2011, Neuro-oncology.

[77]  P. Zabel,et al.  Myeloid‐derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties , 2011, Journal of leukocyte biology.

[78]  I. Messaoudi,et al.  Nonhuman primate models of human immunology. , 2011, Antioxidants & redox signaling.

[79]  J. Casanova,et al.  Human CD14dim Monocytes Patrol and Sense Nucleic Acids and Viruses via TLR7 and TLR8 Receptors , 2010, Immunity.

[80]  Claudio Lottaz,et al.  Comparison of gene expression profiles between human and mouse monocyte subsets. , 2010, Blood.

[81]  J. Ochoa,et al.  Nature of myeloid cells expressing arginase 1 in peripheral blood after trauma. , 2009, The Journal of trauma.

[82]  C. Divino,et al.  Immune stimulatory receptor CD40 is required for T-cell suppression and T regulatory cell activation mediated by myeloid-derived suppressor cells in cancer. , 2010, Cancer research.

[83]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[84]  M. Atkins,et al.  Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. , 2009, Cancer research.

[85]  Yan Feng.  Regulatory T cells and immune tolerance , 2009 .

[86]  T. Nomura,et al.  Regulatory T Cells and Immune Tolerance , 2008, Cell.

[87]  M. Colombo,et al.  The terminology issue for myeloid-derived suppressor cells. , 2007, Cancer research.

[88]  Z. Trajanoski,et al.  Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.

[89]  B. Baban,et al.  GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. , 2005, Immunity.

[90]  S. Signoretti,et al.  Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. , 2005, Cancer research.

[91]  M. Stephens,et al.  A Demographic Analysis of Primate Research in the United States , 2004, Alternatives to laboratory animals : ATLA.

[92]  L. Bouzas,et al.  T-lymphocyte function from peripheral blood stem-cell donors is inhibited by activated granulocytes. , 2003, Cytotherapy.

[93]  Christian Bogdan,et al.  Nitric oxide and the immune response , 2001, Nature Immunology.

[94]  O. Finn,et al.  Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients. , 2001, Cancer research.